Assignee
TISENTO THERAPEUTICS INC
US·5 granted patents·11 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
16 records- 0181US2026000653A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0279US2025108040A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0378US2025270219A1Process for preparing soluble guanylate cyclase stimulatorsTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0476US2023381153A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0574US2025243205A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0673US12054489B2Substituted amidrazones as intermediates in the process for preparing soluble guanylate cyclase stimulatorsTISENTO THERAPEUTICS INC·Filed 2022·Granted Aug 6, 2024·0 cites·12 claims
- 0773US2025326761A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0873US2025059197A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0972US2025115611A1CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1071US11897887B2sGC stimulatorsTISENTO THERAPEUTICS INC·Filed 2018·Granted Feb 13, 2024·1 cites·24 claims
- 1170US12122782B2Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulatorsTISENTO THERAPEUTICS INC·Filed 2022·Granted Oct 22, 2024·0 cites·31 claims
- 1266US12435080B2sGC stimulatorsTISENTO THERAPEUTICS INC·Filed 2021·Granted Oct 7, 2025·0 cites·6 claims
- 1360US2025367191A1Treatment of mitochondrial diseases with a cns-penetrant sgc stimulator zagociguatTISENTO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1458US2024208979A1sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2024207265A1TREATMENT OF CNS DISEASES WITH sGC STIMULATORSTISENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1647US12220414B2Use of sGC stimulators for the treatment of mitochondrial disordersTISENTO THERAPEUTICS INC·Filed 2019·Granted Feb 11, 2025·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when TISENTO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →